-
Making Collaboration More Common for Rare CancersAn AACR Annual Meeting 2022 session highlights the impact of research advocacy partnerships for a variety of cancers.
by Marci A. Landsmann
-
Medicaid: A Partial Safety NetExpansions in coverage and eligibility through the Affordable Care Act have made Medicaid a lifeline for many people with cancer, but benefits vary from state to state.
by Sharon Tregaskis
-
Forward Look
Adequate RepresentationMedical oncologist Lola Fashoyin-Aje describes the Food and Drug Administration’s efforts to make clinical trials more inclusive.
by Erin O'Donnell
-
Policy Matters
Cancer Research: The Key to Tomorrow’s CuresThe AACR is engaging with Congress and the Biden administration on the importance of funding for cancer research.
by David A. Tuveson, MD, PhD
-
Get Involved
Doing Yoga in RecoveryA volunteer program brings yoga to cancer patients in the hospital.
by Bradley Jones
-
Facts and Stats
Fifty Years of Growing SurvivorshipMore people in the U.S. are alive after being diagnosed with cancer than ever before.
by Eric Fitzsimmons
-
From the Editor-in-Chief
Improving Clinical TrialsThe fast pace of drug discovery should be matched by modernized clinical trials for wider access.
by William G. Nelson, MD, PhD
-
Policy Matters
The FDA Takes Steps to Curb Tobacco UseThe federal agency wants to ban menthol-flavored cigarettes, ban all flavors of cigars, and limit nicotine content.
by Nicholas Warren, PhD
-
Get Involved
Cooking Up SupportJohn Hanley's ChemoCookery Twitter account has become a place to share meal ideas and have conversations about cooking, cancer and the crossover between them.
by Bradley Jones
-
Oncology Takes on CannabisPeople take cannabis to treat an array of cancer-related symptoms and side effects. Legal prohibitions have stymied attempts at research into cannabis in cancer patients, but doctors are finding creative ways to study its effects.
by Kate Yandell
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
